Terms: = Prostate cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
178 results:
1. Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced prostate cancer.
Neeb A; Figueiredo I; Gurel B; Nava Rodrigues D; Rekowski J; Riisnaes R; Ferreira A; Miranda S; Crespo M; Westaby D; de Los Dolores Fenor de La Maza M; Guo C; Carmichael J; Grochot R; Tunariu N; Cato ACB; Plymate SR; de Bono JS; Sharp A
Lab Invest; 2023 Nov; 103(11):100245. PubMed ID: 37652207
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the Onset and Progression of prostate cancer through a Multicellular Agent-based Model.
Passier M; van Genderen MNG; Zaalberg A; Kneppers J; Bekers EM; Bergman AM; Zwart W; Eduati F
Cancer Res Commun; 2023 Aug; 3(8):1473-1485. PubMed ID: 37554550
[TBL] [Abstract] [Full Text] [Related]
3. Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring.
Lilleby W; Seierstad T; Inderberg EM; Hole KH
Int J Cancer; 2023 May; 152(10):2166-2173. PubMed ID: 36715014
[TBL] [Abstract] [Full Text] [Related]
4. microRNA-205 in prostate cancer: Overview to clinical translation.
Chauhan N; Manojkumar A; Jaggi M; Chauhan SC; Yallapu MM
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188809. PubMed ID: 36191828
[TBL] [Abstract] [Full Text] [Related]
5. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
6. Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.
Bramhecha YM; Guérard KP; Audet-Walsh É; Rouzbeh S; Kassem O; Pernet E; Scarlata E; Hamel L; Brimo F; Divangahi M; Aprikian AG; Chevalier S; Giguère V; Lapointe J
Oncogene; 2022 May; 41(20):2798-2810. PubMed ID: 35411033
[TBL] [Abstract] [Full Text] [Related]
7. VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in prostate cancer.
Poulose N; Forsythe N; Polonski A; Gregg G; Maguire S; Fuchs M; Minner S; Sauter G; McDade SS; Mills IG
Mol Cancer Res; 2022 Jul; 20(7):1047-1060. PubMed ID: 35348747
[TBL] [Abstract] [Full Text] [Related]
8. Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients.
Belluti S; Semeghini V; Rigillo G; Ronzio M; Benati D; Torricelli F; Reggiani Bonetti L; Carnevale G; Grisendi G; Ciarrocchi A; Dominici M; Recchia A; Dolfini D; Imbriano C
J Exp Clin Cancer Res; 2021 Nov; 40(1):362. PubMed ID: 34782004
[TBL] [Abstract] [Full Text] [Related]
9. A concise review on the role of BDNF-AS in human disorders.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
[TBL] [Abstract] [Full Text] [Related]
10. Role of ZBTB7A zinc finger in tumorigenesis and metastasis.
Singh AK; Verma S; Kushwaha PP; Prajapati KS; Shuaib M; Kumar S; Gupta S
Mol Biol Rep; 2021 May; 48(5):4703-4719. PubMed ID: 34014468
[TBL] [Abstract] [Full Text] [Related]
11. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
[TBL] [Abstract] [Full Text] [Related]
12. NKX3.1 Localization to Mitochondria Suppresses prostate cancer Initiation.
Papachristodoulou A; Rodriguez-Calero A; Panja S; Margolskee E; Virk RK; Milner TA; Martina LP; Kim JY; Di Bernardo M; Williams AB; Maliza EA; Caputo JM; Haas C; Wang V; De Castro GJ; Wenske S; Hibshoosh H; McKiernan JM; Shen MM; Rubin MA; Mitrofanova A; Dutta A; Abate-Shen C
Cancer Discov; 2021 Sep; 11(9):2316-2333. PubMed ID: 33893149
[TBL] [Abstract] [Full Text] [Related]
13. In Vivo Assessment of Metastatic Cell Potential in prostate cancer.
Nunez-Olle M; Guiu M; Gomis RR
Methods Mol Biol; 2021; 2294():253-267. PubMed ID: 33742407
[TBL] [Abstract] [Full Text] [Related]
14.
Cai C; Luo J; Liu Q; Liu Z; Zhao Y; Wu X; Yuegao Y; Lei Y; Lu J; Wang Y; Cai Z; Duan X; Lei M; Gu D; Liu Y
Genet Test Mol Biomarkers; 2021 Feb; 25(2):131-139. PubMed ID: 33596143
[No Abstract] [Full Text] [Related]
15. Doublecortin Expression in prostate Adenocarcinoma and Neuroendocrine Tumors.
Tabrizi S; Alshalalfa M; Mahal BA; Davicioni E; Liu Y; Mouw KW; Feng F; Nguyen PL; Muralidhar V
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):936-940. PubMed ID: 32585335
[TBL] [Abstract] [Full Text] [Related]
16. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract] [Full Text] [Related]
17. cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.
Müller I; Strozyk E; Schindler S; Beissert S; Oo HZ; Sauter T; Lucarelli P; Raeth S; Hausser A; Al Nakouzi N; Fazli L; Gleave ME; Liu H; Simon HU; Walczak H; Green DR; Bartek J; Daugaard M; Kulms D
Mol Cell; 2020 Mar; 77(5):970-984.e7. PubMed ID: 31982308
[TBL] [Abstract] [Full Text] [Related]
18. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?
Chun JN; Cho M; Park S; So I; Jeon JH
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188336. PubMed ID: 31870703
[TBL] [Abstract] [Full Text] [Related]
19. BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Loveridge CJ; Slater S; Campbell KJ; Nam NA; Knight J; Ahmad I; Hedley A; Lilla S; Repiscak P; Patel R; Salji M; Fleming J; Mitchell L; Nixon C; Strathdee D; Neilson M; Ntala C; Bryson S; Zanivan S; Edwards J; Robson CN; Goodyear CS; Blyth K; Leung HY
Oncogene; 2020 Feb; 39(8):1797-1806. PubMed ID: 31740786
[TBL] [Abstract] [Full Text] [Related]
20. Role of miRNA-Regulated cancer Stem Cells in the Pathogenesis of Human Malignancies.
Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
[TBL] [Abstract] [Full Text] [Related]
[Next]
